- Clinical Areas /
- Neurology
Neurology
Amyloid Beta Plaque Formation in Alzheimer’s Disease
This excerpt shows a stylized version of Alzheimer’s disease, focusing on the accumulation and aggregation of amyloid beta (Aβ) peptides. Aberrant proteolytic cleavage of amyloid precursor protein (APP) by β- and γ-secretases results in the production of aggregation-prone Aβ isoforms, predominantly Aβ₁₋₄₀ and Aβ₁₋₄₂ [1,2]. These monomers undergo misfolding, oligomerization, and ultimately fibrillogenesis, forming insoluble plaques within the extracellular space of cortical and hippocampal neurons.
The animation captures the cellular impact of these deposits, including disruption of synaptic signaling, induction of oxidative stress, and microglial activation—hallmarks of early Alzheimer’s pathology [3,4]. This sequence is part of a broader mechanism of action (MOA) animation intended to support scientific communication in neurology, pharmaceutical development, and medical education.
References:
-
Hardy, J., & Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science, 297(5580), 353–356.
-
Haass, C., & Selkoe, D. J. (2007). Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid β-peptide. Nature Reviews Molecular Cell Biology, 8(2), 101–112.
-
Walsh, D. M., & Selkoe, D. J. (2007). Aβ oligomers – a decade of discovery. Journal of Neurochemistry, 101(5), 1172–1184.
-
Heneka, M. T., et al. (2015). Neuroinflammation in Alzheimer’s disease. The Lancet Neurology, 14(4), 388–405.
Neurology Medical Animation FAQs
How can animation explain amyloid-beta plaque formation?
Animation can show amyloid-beta peptides accumulating and forming larger aggregates within a neural environment. By moving between molecular detail and the surrounding brain tissue, it helps audiences understand the physical process represented by the term “plaque formation.”
Why move between brain and molecular views in neurology animation?
Neurological disease can be discussed at several levels: the whole brain, a neural network, individual neurons, and molecular interactions. Animation provides a way to travel between those levels while retaining a clear connection between the process being depicted and its biological setting.
How should a neurological disease process be presented responsibly?
The animation should be precise about the mechanism it is illustrating and should not turn a visual explanation of one biological feature into a broader claim about disease causation, progression, or therapeutic effect. The relevant scientific sources and approved narrative should guide every stage of the depiction.
Next Steps
If you are interested in speaking to a medical animation expert, please get in touch.
Get in touch